Healthcare -
Biotechnology - NASDAQ - US
$ 5.655
-1.82 %
$ 347 M
Market Cap
-3.18
P/E
GLUE - CHANGE IN WORKING CAPITAL
Change in Working Capital GLUE - Monte Rosa Therapeutics, Inc.
72.5 M
LAST VALUE
239.53%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR